TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
7.47
-0.06 (-0.80%)
Dec 24, 2025, 1:00 PM EST - Market closed
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $6.81 million as of December 24, 2025. Its market cap has increased by 68.47% in one year.
Market Cap
6.81M
Enterprise Value
3.98M
1-Year Change
68.47%
Ranking
Category
Stock Price
$7.47
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $6.81M, a decrease of -85.77%. That is a compound annual growth rate of -35.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 6.81M | 190.37% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
| Jul 9, 2021 | 47.87M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.66B |
| Johnson & Johnson | 495.06B |
| AbbVie | 405.72B |
| UnitedHealth Group | 294.40B |
| AstraZeneca | 284.34B |
| Novartis AG | 263.31B |
| Merck & Co. | 259.79B |
| Novo Nordisk | 232.28B |